Nuvation Bio NUVB Selling Expense
Selling Expense at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:SellingExpense.
The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's selling expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nuvation Bio's selling expense?
- Nuvation Bio (NUVB) reported selling expense of $375K in Q1 2026.
- What does selling expense mean?
- This metric represents the costs incurred by the company to market, promote, and distribute its products or services to customers. It encompasses expenditures related to sales force compensation, advertising campaigns, and general commercialization efforts. Monitoring this expense helps investors evaluate the efficiency of the company's go-to-market strategy and its ability to drive revenue growth relative to sales investment.